What is the current valuation of the metered dose-inhalers market in France?

The market valuation was $641.25 Million in 2024. Read More

What is the projected market size for metered dose-inhalers in France by 2035?

The projected valuation for 2035 is $1,450.0 Million. Read More

What is the expected CAGR for the metered dose-inhalers market in France during the forecast period?

The expected CAGR for the market from 2025 - 2035 is 7.7%. Read More

What are the main product segments in the France metered dose-inhalers market?

The main product segments are Press Metered Dose Inhalers and Breath Actuated Metered Dose Inhalers. Read More

What was the market value for Press Metered Dose Inhalers in 2024?

The market value for Press Metered Dose Inhalers was $400.0 Million in 2024. Read More

What is the market value for Breath Actuated Metered Dose Inhalers projected for 2035?

The market value for Breath Actuated Metered Dose Inhalers is projected to reach $550.0 Million by 2035. Read More

What are the leading propellant types used in metered dose-inhalers in France?

Leading propellant types include HFA 134a, HFA 227ea, and HFA-152a. Read More

What is the market value for HFA 134a in 2024?

The market value for HFA 134a was $256.56 Million in 2024. Read More

Which distribution channels are most prominent for metered dose-inhalers in France?

Prominent distribution channels include Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Read More

France Metered Dose Inhalers Market

Q: Which companies are the key players in the France metered dose-inhalers market?

Key players include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries, Mylan, Roche, Sanofi, and Pfizer. Read More

ID: MRFR/HC/48602-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

France Metered Dose Inhalers Market Research Report By Product (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By Propellant Type (HFA 134A, HFA 227EA, HFA 152A), By Technology (Pulmonary Platform Technologies, Nasal Platform Technologies), By Indication (Asthma, COPD, Others) and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) -Forecast to 2035

France Metered Dose Inhalers Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)7.7%

2024 Market Size$ 641.25 Million

2025 Market Size$ 690.63 Million

2035 Market Size$ 1,450 Million

Key Players

AstraZeneca

Boehringer Ingelheim

GlaxoSmithKline

Novartis

Teva Pharmaceutical Industries

Mylan

Trends

Technological Advancements
Regulatory Support
Patient Education and Awareness

Opportunities

Advancements in Inhaler Technology
Government Initiatives and Funding
Rising Prevalence of Respiratory Diseases

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Product (USD Million)
  1. 4.1.1 Press Metered Dose Inhalers
  2. 4.1.2 Breath Actuated Metered Dose Inhalers
2. 4.2 Food, Beverages & Nutrition, BY Propellant Type (USD Million)
  1. 4.2.1 HFA 134a
  2. 4.2.2 HFA 227ea
  3. 4.2.3 HFA-152a
3. 4.3 Food, Beverages & Nutrition, BY Technology (USD Million)
  1. 4.3.1 Pulmonary Platform Technologies
  2. 4.3.2 Nasal Platform Technologies
4. 4.4 Food, Beverages & Nutrition, BY Indication (USD Million)
  1. 4.4.1 Asthma
  2. 4.4.2 COPD
  3. 4.4.3 Others
5. 4.5 Food, Beverages & Nutrition, BY Distribution Channel (USD Million)
  1. 4.5.1 Hospital Pharmacies
  2. 4.5.2 Retail Pharmacies
  3. 4.5.3 Online Pharmacies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 AstraZeneca (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boehringer Ingelheim (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 GlaxoSmithKline (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Novartis (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Teva Pharmaceutical Industries (IL)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Mylan (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Roche (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sanofi (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Pfizer (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY PRODUCT
3. 6.3 FRANCE MARKET ANALYSIS BY PROPELLANT TYPE
4. 6.4 FRANCE MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 FRANCE MARKET ANALYSIS BY INDICATION
6. 6.6 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7. 6.7 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
10. 6.10 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
12. 6.12 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY PRODUCT, 2024 (% SHARE)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY PRODUCT, 2024 TO 2035 (USD Million)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY PROPELLANT TYPE, 2024 (% SHARE)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY PROPELLANT TYPE, 2024 TO 2035 (USD Million)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY TECHNOLOGY, 2024 (% SHARE)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY INDICATION, 2024 (% SHARE)
20. 6.20 FOOD, BEVERAGES & NUTRITION, BY INDICATION, 2024 TO 2035 (USD Million)
21. 6.21 FOOD, BEVERAGES & NUTRITION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
22. 6.22 FOOD, BEVERAGES & NUTRITION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  2. 7.2.2 BY PROPELLANT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
  4. 7.2.4 BY INDICATION, 2025-2035 (USD Million)
  5. 7.2.5 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France Metered Dose Inhalers Market Segmentation

France Metered Dose Inhalers Market By Product (USD Million, 2025-2035)

Press Metered Dose Inhalers
Breath Actuated Metered Dose Inhalers

France Metered Dose Inhalers Market By Propellant Type (USD Million, 2025-2035)

HFA 134a
HFA 227ea
HFA-152a

France Metered Dose Inhalers Market By Technology (USD Million, 2025-2035)

Pulmonary Platform Technologies
Nasal Platform Technologies

France Metered Dose Inhalers Market By Indication (USD Million, 2025-2035)

Asthma
COPD
Others

France Metered Dose Inhalers Market By Distribution Channel (USD Million, 2025-2035)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”